NCT06015542
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Odense University Hospital Odense, Denmark
- Department of Heamatology Vejle, Denmark
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,958 public trials
2,018 recruiting studies
Immunoproliferative Disorders trial results
NCT06484920
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +13 more
- Locations
-
- Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Sidney and Lois Eskenazi Hospital Indianapolis, Indiana, United States
NCT04368702
- Conditions
- Bladder Cancer, Breast Carcinoma In Situ, Breast Diseases, +44 more
- Locations
-
- Brigham & Women's Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT07105059
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
The PRE-VAIL Study
NCT07176624
- Conditions
- ARDS (Moderate or Severe), Enteral Nutrition Feeding, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- The First Hospital of Jilin University Changchun, Jilin, China
NCT03938987
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Foothills Medical Centre Calgary, Alberta, Canada
- Tom Baker Cancer Centre Calgary, Alberta, Canada
- Alberta Children's Hospital Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
NCT07397832
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Tianjin Medical University Cancer Insititute & Hospital Tianjin, Tianjin Municipality, China
NCT04883437
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +18 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT04895436
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
- Locations
-
- Moores Cancer Center at UC San Diego /ID# 230157 La Jolla, California, United States
- Winship Cancer Institute of Emory University /ID# 230643 Atlanta, Georgia, United States
- Des Moines Oncology Research Association /ID# 232606 Des Moines, Iowa, United States
- Dana-Farber Cancer Institute /ID# 230061 Boston, Massachusetts, United States
Recruiting
Pediatric PET/MR Image Registry
NCT03458520
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States